Table 1 Demographic, clinical data and outcome among severe and non-severe patients (no. = 267).

From: Coagulation parameters abnormalities and their relation to clinical outcomes in hospitalized and severe COVID-19 patients: prospective study

Characteristics

Severity

P value

Non-severe (no. = 196)

Severe (no. = 71)

Age

Mean ± S.D

39.59 ± 15.62

52.65 ± 14.92

 < 0.001*

Median (Range)

34 (18–87)

55 (26–85)

Sex

Male

117 (59.7%)

33 (46.5%)

0.055

Female

79 (40.3%)

38 (53.5%)

 

Fever

144 (73.5%)

39 (54.9%)

0.004

Cough

104 (53.1%)

46 (64.8%)

0.088

Dyspnea

70 (35.7%)

65 (91.5%)

 < 0.001

Coagulation abnormalities

46 (23.1%)

51 (71.8%)

 < 0.001

Death

Died

0 (0.0%)

8 (11.3%)

 < 0.001#

No

196 (100%)

63 (88.7%)

  1. P-value was calculated by Chi-Square Test.
  2. *P-value was calculated by Mann Whitney test.
  3. #P-value was calculated by Fisher's Exact Test.
  4. P-value < 0.05 is statistically significant.